Non‐insulin antihyperglycaemic drugs and heart failure: an overview of current evidence from randomized controlled trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Non‐insulin antihyperglycaemic drugs and heart failure: an overview of current evidence from randomized controlled trials

Published:2020-09-10 Issue:6 Volume:7 Page:3438-3451
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Savarese Gianluigi¹,Schrage Benedikt¹,Cosentino Francesco¹,Lund Lars H.¹,Rosano Giuseppe M.C.²³,Seferovic Petar⁴⁵,Butler Javed⁶

Affiliation:

1. Division of Cardiology, Department of Medicine Karolinska Institutet Stockholm 17176 Sweden

2. Department of Medical Sciences IRCCS San Raffaele Rome Italy

3. Cardiology Clinical Academic Group St George's Hospitals NHS Trust University of London London UK

4. Faculty of Medicine University of Belgrade Belgrade Serbia

5. Serbian Academy of Sciences and Arts Belgrade Serbia

6. Department of Medicine University of Mississippi Jackson MS USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.12937

Reference96 articles.

1. Global Public Health Burden of Heart Failure

2. Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030

3. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry

4. Congestive Heart Failure in Type 2 Diabetes

5. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of SGLT2 inhibitors in patients with heart failure: An overview of systematic reviews;International Journal of Cardiology;2023-04

2. Neutral effect of SGLT2 inhibitors on lipoprotein metabolism: From clinical evidence to molecular mechanisms;Pharmacological Research;2023-02

3. Discovery and development of tricyclic matrinic derivatives as anti-diabetic candidates by AMPKα activation;Chinese Chemical Letters;2023-01

4. Metformin, Sulfonylureas, DPP-4 Inhibitors and Cardiovascular Outcomes in Type 2 DM;Diabetes and Cardiovascular Disease;2023

5. Contemporary choice of glucose lowering agents in heart failure patients with type 2 diabetes;Expert Opinion on Pharmacotherapy;2022-11-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3